期刊文献+

艾滋病合并重度血小板减少临床特征分析

Clinical feature analysis of AIDS complicated with severe thrombocytopenia
下载PDF
导出
摘要 目的报告艾滋病合并重度血小板减少患者3例,并结合文献搜索讨论其有效治疗方法,为进一步提高临床诊治提供经验。方法回顾分析3例艾滋病合并重度血小板减少患者的临床资料,讨论其有效治疗方法。结果3例患者临床表现主要为全身皮肤瘀点、瘀斑,其中2例伴发黏膜出血。3例患者中2例在出现血小板减少时未启动抗病毒治疗,另1例患者已行抗病毒治疗2年,但CD4+T淋巴细胞计数仍<200个/μl。3例患者均使用甲泼尼松龙联合强效抗病毒治疗,后续贯泼尼松龙巩固治疗。1例患者激素治疗无效,行脾切除术。经过治疗3例患者血小板均逐渐恢复并出院。结论HIV相关性血小板减少的发生可能与HIV在体内持续活跃复制有关,早期以强效抗病毒治疗联合激素冲击疗法为首选方案,可明显改善患者生活质量及结局。 Objective To report 3 patients of AIDS complicated with severe thrombocytopenia,discuss the effective treatment based on the literature retrieval,and provide experience for further improvement of clinical diagnosis and treatment.Methods Clinical data of AIDS complicated with severe thrombocytopenia were analyzed retrospectively to discuss the effective treatment.Results The main clinical manifestation of 3 patients included petechiae or suggillation in the systemic skin,and was associated mucosal hemorrhage in 2 cases.Two of 3 patients did not initiate antiviral therapy in the presence of thrombocytopenia,while 1 of 3 patients had been on antiviral therapy for 2 years,but CD4+T lymphocytes were still less than 200 cells/μl.All 3 patients were treated with methylprednisolone combined with strong antiviral therapy,followed by prednisolone consolidation therapy.One patient did not respond to hormone therapy and underwent splenectomy.After treatment,the platelets of all 3 patients recovered gradually,and they were discharged.Conclusions The occurrence of primary HIV-associated thrombocytopenia may be related to the continuous active replication of HIV in vivo.Early strong antiviral therapy combined with hormone shock therapy is the preferred regimen,which can significantly improve the patient’s quality of life and outcome.
作者 王茜 孙丽君 刘安 画伟 叶江竹 代丽丽 WANG Xi;SUN Li-jun;LIU An;HUA Wei;YE Jiang-zhu;DAI Li-li(STD/AIDS Clinic,Center for Infectious Diseases,Beijing Youan Hospital,Capital Medical University,100069,China)
出处 《传染病信息》 2021年第5期429-433,共5页 Infectious Disease Information
关键词 人类免疫缺陷病毒 血小板减少 抗反转录病毒治疗 human immunodeficiency virus thrombocytopenia antiretroviral therapy
  • 相关文献

参考文献6

二级参考文献58

  • 1孔圆,黄晓军.《阿托伐他汀能够改善激素耐药型免疫性血小板减少患者的骨髓血管内皮细胞功能》解读[J].临床血液学杂志,2020,33(1):1-5. 被引量:4
  • 2叶义红,陈卫诚,刘兰,孟江华.艾滋病25例临床分析[J].临床军医杂志,2005,33(4):435-436. 被引量:8
  • 3李韩平,刘伟,刘海霞,梁淑家,鲍作义,刘永建,庄道民,刘思扬,李林,李敬云.广西壮族自治区133例艾滋病患者抗病毒治疗效果评价[J].中华流行病学杂志,2007,28(4):338-342. 被引量:43
  • 4ProvanD, StasiR, NewlandAC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia[J]. Blood,2010,115(2):168-186.
  • 5NeunertC, LimW, CrowtherM, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia[J]. Blood,2011,117(16):4190-4207.
  • 6British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy[J]. Br J Haematol,2003,120(4):574-596. doi:10.1046/j.1365-2141.2003.04131.x.
  • 7WeiY, JiXB, WangYW, et al. High-dose dexamethasone versus prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial[J]. Blood,2016,127(3):296-302. doi:10.1182/blood-2015-07-659656.
  • 8WangS, YangR, ZouP, et al. A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia[J]. Int J Hematol,2012,96(2):222-228. doi:10.1007/s12185-012-1124-8.
  • 9BusselJB, ChengG, SalehMN, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura[J]. N Engl J Med,2007,357(22):2237-2247. doi:10.1056/NEJMoa073275.
  • 10BusselJB, ProvanD, ShamsiT, et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, doubleblind, placebo-controlled trial[J]. Lancet,2009,373(9664):641-648. doi:10.1016/S0140-6736(09)60402-5.

共引文献824

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部